These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 33940030

  • 1. RS4651 suppresses lung fibroblast activation via the TGF-β1/SMAD signalling pathway.
    Li S, Xu A, Li Y, Tan C, La Regina G, Silvestri R, Wang H, Qi W.
    Eur J Pharmacol; 2021 Jul 15; 903():174135. PubMed ID: 33940030
    [Abstract] [Full Text] [Related]

  • 2. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F, Mou C.
    Med Sci Monit; 2020 Feb 05; 26():e919739. PubMed ID: 32019905
    [Abstract] [Full Text] [Related]

  • 3. Total extract of Xin Jia Xuan Bai Cheng Qi decoction inhibits pulmonary fibrosis via the TGF-β/Smad signaling pathways in vivo and in vitro.
    Qin H, Wen HT, Gu KJ, Hu XD, Yang T, Yan XF, Ye TJ, Huo JL, Hu J.
    Drug Des Devel Ther; 2019 Feb 05; 13():2873-2886. PubMed ID: 31695321
    [Abstract] [Full Text] [Related]

  • 4. USP7 Promotes TGF-β1 Signaling by De-Ubiquitinating Smad2/Smad3 in Pulmonary Fibrosis.
    Tang F, Gong H, Ke T, Yang W, Yang Y, Liu Z.
    Discov Med; 2024 Aug 05; 36(187):1616-1626. PubMed ID: 39190377
    [Abstract] [Full Text] [Related]

  • 5. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
    Luo L, Wang CC, Song XP, Wang HM, Zhou H, Sun Y, Wang XK, Hou S, Pei FY.
    Biomed Pharmacother; 2018 Sep 05; 105():841-847. PubMed ID: 30021376
    [Abstract] [Full Text] [Related]

  • 6. Urine-Derived Stem Cells Reverse Bleomycin‑Induced Experimental Pulmonary Fibrosis by Inhibition of the TGF-β1-Smad2/3 Pathway.
    Zhang Y, Xia Y, Zhang R, Zhou X, Jiang J.
    Cytotherapy; 2024 Oct 05; 26(10):1236-1244. PubMed ID: 38852093
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Baccatin III ameliorates bleomycin-induced pulmonary fibrosis via suppression of TGF-β1 production and TGF-β1-induced fibroblast differentiation.
    Nie Y, Zhang D, Qian F, Wu Y.
    Int Immunopharmacol; 2019 Sep 05; 74():105696. PubMed ID: 31229901
    [Abstract] [Full Text] [Related]

  • 10. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F, Zhuang Y, Sides MD, Sanchez CG, Shan B, White ES, Lasky JA.
    Respir Res; 2014 Apr 24; 15(1):51. PubMed ID: 24762191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nagilactone D ameliorates experimental pulmonary fibrosis in vitro and in vivo via modulating TGF-β/Smad signaling pathway.
    Li A, Xiao X, Feng ZL, Chen X, Liu LJ, Lin LG, Lu JJ, Zhang LL.
    Toxicol Appl Pharmacol; 2020 Jan 15; 389():114882. PubMed ID: 31953203
    [Abstract] [Full Text] [Related]

  • 14. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.
    Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E.
    J Exp Med; 2010 Aug 02; 207(8):1589-97. PubMed ID: 20643828
    [Abstract] [Full Text] [Related]

  • 15. 8-Oxoguanine DNA glycosylase modulates the cell transformation process in pulmonary fibrosis by inhibiting Smad2/3 and interacting with Smad7.
    Wang Y, Chen T, Pan Z, Lin Z, Yang L, Zou B, Yao W, Feng D, Huangfu C, Lin C, Wu G, Ling H, Liu G.
    FASEB J; 2020 Oct 02; 34(10):13461-13473. PubMed ID: 32808374
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Digoxin alleviates pulmonary fibrosis by regulating phosphatidylinositol-3-kinase/Akt signaling through inhibiting the activation of fibroblast: an in vivo and in vitro experiment].
    Jia L, Yang M, Tian X, Zhao P, Mei X, Bai Y.
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Nov 02; 34(11):1161-1166. PubMed ID: 36567559
    [Abstract] [Full Text] [Related]

  • 20. Derrone Targeting the TGF Type 1 Receptor Kinase Improves Bleomycin-Mediated Pulmonary Fibrosis through Inhibition of Smad Signaling Pathway.
    Molagoda IMN, Sanjaya SS, Lee KT, Choi YH, Lee JH, Lee MH, Kang CH, Lee CM, Kim GY.
    Int J Mol Sci; 2023 Apr 14; 24(8):. PubMed ID: 37108428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.